Loading...

Actinogen Medical Limited

ATGGF•PNK
Healthcare
Biotechnology
$0.03
$0.00(0.00%)

Actinogen Medical Limited (ATGGF) Stock Overview

Explore Actinogen Medical Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.3/100

Key Financials

Market Cap79.4M
P/E Ratio-59.35
EPS (TTM)N/A
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Week$0.00
1 Month$0.01
3 Months$0.01
1 Year Target$0.04

ATGGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Actinogen Medical Limited (ATGGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 79.79, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -59.35 and a market capitalization of 79.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
25.00%
6-Month Change
66.67%
Year-to-Date (YTD) Change
25.00%
1-Year Change
66.67%
3-Year Change
4.17%
5-Year Change
-28.57%
All-Time (Max) Change
-50.98%

Contact Information

https://www.actinogen.com.au
61 2 8964 7401
109 Pitt Street, Sydney, NSW, 2000

Company Facts

IPO DateSep 18, 2018
CountryAU
Actively Trading

Frequently Asked Questions

;